Advertisement

Journal of Clinical Immunology

, Volume 2, Issue 4, pp 309–313 | Cite as

Basophil activation in idiopathic mixed cryoglobulinemia

  • Antonio Miadonna
  • Alberto Tedeschi
  • Ennio Leggieri
  • Fulvio Invernizzi
  • Carlo Zanussi
Original Articles

Abstract

We studied basophil activation in patients affected by idiopathic mixed cryoglobulinemia in order to investigate the role of the basophil cell in the pathogenesis of the vasculitis typical of this disease. We selected 13 patients and we performed thein vitro basophil degranulation test with cryoprecipitate; in 5 cases the test was positive when it was performed in whole blood, while it was negative when it was performed with cells washed and resuspended in Tyrode's buffer. In 6 subjects it was not possible to perform the test because of the very low number of circulating basophil cells. Finally, in 2 subjects thein vitro basophil degranulation test with cryoprecipitate was negative; this result may be related to the very low levels of complement factors in the sera of these subjects. These findings sugges that the pathogenetic mechanism of vasculitis in idiopathic mixed cryoglobulinemia could be started by basophil activation.

Key words

Cryoglobulinemia basophil cells immune complexes complement 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Benveniste J, Egido T, Gutierrez Millet V, Camussi G: Detection of immediate hypersensitivity in rabbits by direct basophil degranulation. J. Allergy Clin Immunol 59(4):271–279, 1977Google Scholar
  2. 2.
    Ceska M, Eriksson R, Varga JM: Radioimmunosorbent assay of allergens. J Allergy Clin Immunol 49:1–9, 1972Google Scholar
  3. 3.
    Ceska M, Lundqvist V: A new and simple radio-immunoassay method for the determination of IgE. Immunochemistry 9:1021–1030, 1972Google Scholar
  4. 4.
    Cochrane CG: Studies on localization of circulating antigen-antibody complexes and other macromolecules in vessels. II. Pathogenetic and pharmacodynamic studies. J Exp Med 118:503–513, 1963Google Scholar
  5. 5.
    Findlay SR, Lichtenstein LM, Grant JA: Generation of slow reacting substance by human leukocytes. II. Comparison of stimulation by antigen, anti IgE, Calcium ionophore and C5 peptide 124(1):238–242, 1980Google Scholar
  6. 6.
    Glovsky M, Hugli T, Ishizaka T, Lichtenstein LM: Studies of C3ahu on human leukocyte binding and histamine release. Fed Proc 36:1264, 1977 (abstr)Google Scholar
  7. 7.
    Grant JA, Dupree E, Goldman HS, Schultz DK, Tackson AL: Complement induced release of histamine in human leukocytes. J Immunol 114:1101–1106, 1979Google Scholar
  8. 8.
    Hugli TE, Muller Eberhard HJ: Anaphylatoxins: C3a and C5a. Adv Immunol 26:1–53, 1978Google Scholar
  9. 9.
    Kniker WT, Cochrane CG: The localization of circulating immune complexes in experimental serum sickness. The role of vasoactive amines and hydrodynamic forces. J Exp Med 127:119–136, 1968Google Scholar
  10. 10.
    Linskott WD, Kane JP: The complement system in cryoglobulinaemia. Interaction with immunoglobulins and lipoproteins. Clin Exp Immunol 21:510–519, 1975Google Scholar
  11. 11.
    Siraganian RP, Hook WA: Complement induced histamine release from human basophils. II. Mechanism of histamine release reaction. J Immunol 116:639–644, 1976Google Scholar
  12. 12.
    Wide L, Bennich H, Johansson SGO: Diagnosis of allergy by an in vitro test for allergen antibodies. Lancet 2:1105–1108, 1967Google Scholar

Copyright information

© Plenum Publishing Corporation 1982

Authors and Affiliations

  • Antonio Miadonna
    • 1
  • Alberto Tedeschi
    • 1
  • Ennio Leggieri
    • 1
  • Fulvio Invernizzi
    • 1
  • Carlo Zanussi
    • 1
  1. 1.Istituto di Clinica Medica II dell'Università di MilanoMilanoItaly

Personalised recommendations